KURA: Kura Oncology, Inc. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 10 sales totaling $1.26M in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-09-29Ford KathleenOfficer$39Kyes
2026-09-29Leoni MollieOfficer$310K
2026-09-29Powl Brian T.Officer$166K
2026-09-28Bair Teresa BrophyOfficer$89Kyes
2026-09-28Ford KathleenOfficer$72Kyes
2026-09-28Leoni MollieOfficer$131K
2026-09-28Doyle Thomas JamesOfficer$48K
2026-09-28Powl Brian T.Officer$95K
2026-09-28Powl Brian T.Officer$84K
2026-09-24Burrows FrancisOfficer$225K

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-1413G amendmentMontanova Capital, LLC9.70%SEC

Institutional ownership (Q2 2026)

221 institutions reported holding $948.28M of Kura Oncology, Inc. on Form 13F (222 the quarter before). 25 opened a new position and 26 sold out. Shares held by institutions: +3%.

Largest holdersSharesValue
BlackRock, Inc.10,509,233$115.29M
MONTANOVA CAPITAL, LLC8,575,422$94.07M
BVF INC/IL8,445,769$92.65M
STATE STREET CORP5,329,208$58.46M
VANGUARD CAPITAL MANAGEMENT LLC3,916,164$42.96M
ARMISTICE CAPITAL, LLC3,678,000$40.35M
AQR CAPITAL MANAGEMENT LLC3,126,727$34.30M
GOLDMAN SACHS GROUP INC2,265,171$24.85M
GEODE CAPITAL MANAGEMENT, LLC2,229,958$24.47M
ALETHEA CAPITAL MANAGEMENT, LLC2,167,938$23.78M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.